Shin Nihonyanagi
Kitasato University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shin Nihonyanagi.
Journal of Medical Microbiology | 2015
Yoko Takayama; Yuzuru Adachi; Shin Nihonyanagi; Ryoichi Okamoto
Increasing numbers of clinical isolates of Enterobacteriaceae that produce carbapenemase are now being detected, with the most common carbapenemase found among Enterobacteriaceae in Japan being IMP-1-type metallo-β-lactamase. Clinical isolates of Enterobacteriaceae harbouring carbapenemases may be resistant to carbapenem antimicrobial agents, despite apparent in vitro susceptibility when tested according to Clinical and Laboratory Standards Institute criteria. We evaluated the prevalence of carbapenemase producers among isolates of Enterobacteriaceae at our hospital and assessed the performance of the modified Hodge test (MHT) for correctly identifying the phenotype. We studied 47 clinical isolates obtained between 2006 and 2010 for which the MIC of imipenem was 2 or 4 μg imipenem ml- 1. Antibacterial susceptibility testing was done for cephalosporins and carbapenems, the MHT was performed with meropenem and detection of the genes encoding IMP-1, VIM-2, KPC-2 and NDM-1-type metallo-β-lactamases was performed by PCR. Twelve isolates showed a positive result in the MHT with meropenem and were classified as carbapenemase producers. Of these 12 isolates, seven carried the gene for IMP-1 type, but not for VIM-2, KPC-2 or NDM-1 types. None of the carbapenemase genes tested were detected in the other five isolates. All five isolates were Enterobacter cloacae showing high resistance to ceftazidime and aztreonam. False-positive results were inhibited when Mueller-Hinton agar supplemented with 200 mg cloxacillin ml- 1 was used for the MHT. Five of 12 MHT-positive isolates were shown to have no carbapenemase genes and these isolates were high AmpC producers. Adding cloxacillin when performing the MHT prevented such false-positive results. The MHT with cloxacillin can overcome most problems related to detection of carbapenemases.
Journal of Infection and Chemotherapy | 2017
Yoko Takayama; Hidehito Matsui; Yuzuru Adachi; Shin Nihonyanagi; Tatsuhiko Wada; Junko Mochizuki; Nobuya Unno; Hideaki Hanaki
BACKGROUND Infection with Streptococcus agalactiae (Group B streptococcus: GBS) is a significant cause of morbidity and mortality in neonates. Screening for GBS is mainly done by culture-based methods, but a reliable result may take several days to obtain and culture is difficult to perform at institutions without a laboratory. We evaluated an immunochromatography method for rapid detection of GBS-specific surface immunogenic protein (Sip) using anti-Sip monoclonal antibodies. MATERIALS AND METHODS A total of 377 cervical and vaginal swabs collected during weeks 35-37 of gestation were inoculated into GBS medium F and incubated. Growth of microorganisms and production of red/orange pigment were assessed by observation. Then culture extracts were subjected to immunochromatography and were also inoculated onto chromID Strepto B (STRB) medium, after which isolates were serotyped and characterized by PCR. RESULTS Of the 377 samples, 54 (14.3%) were positive for GBS by immunochromatography after incubation in GBS medium F. On the other hand, GBS was isolated from 58 (15.4%) of the 377 samples by culture with GBS medium F and STRB medium. Ten of the 58 isolates were non-pigmented and 4 of these were not detected by immunochromatography. The sensitivity, specificity, positive predictive value, and negative predictive value of immunochromatography were 93.1% (54/58), 100% (319/319), 100% (54/54), and 98.8% (319/323), respectively. CONCLUSIONS Immunochromatography was comparable to culture on STRB medium for detecting GBS, indicating that this method could be used clinically for GBS screening in pregnant women even at small institutions.
Clinical Case Reports | 2015
Shin Nihonyanagi; Keisuke Sunakawa; Longzhu Cui; Tsuguto Masaki; Tatsuhiko Wada; Takayuki Hoshiyama; Masaki Nakamura; Yoko Takayama; Yuhsaku Kanoh; Akifumi Ogawa; Masayoshi Shichiri; Hideaki Hanaki
We report here a very rare case of primary meningococcal arthritis of the knee joint without clinical features associated with meningococcemia, meningitis, or meningococcal complications. The patient suffered from diabetes mellitus and had experienced two episodes of joint trauma. Intravenous infusion of ampicillin/sulbactam for 18 consecutive days was successful.
Modern Rheumatology | 2018
Yojiro Minegishi; Katsufumi Uchiyama; Keizo Sakurai; Shiro Ibe; Hiromi Kanda; Shin Nihonyanagi; Masaki Nakamura; Shinsuke Ikeda; Masashi Takaso
Abstract Objectives: Polymerase chain reaction (PCR)-based assays are being increasingly used for the diagnosis of orthopedic-related infections. Unfortunately, classical PCR requires imaging devices that are expensive and complex. We previously developed the PCR-lateral flow (PCR-LF) method, which does not require any additional imaging device. In the present study, the objective was to determine whether PCR-LF tests could be used to effectively diagnose orthopedic-related infections. Methods: In this study, we used PCR-LF to diagnose common causes of orthopedic-related infections and compared the results to those from conventional bacterial cultures of the same samples. Results: Notably, for 228 synovial fluid or pus specimens, the sensitivity and specificity of bacterial cultures were 53.5% and 97.7%, respectively, compared to 61.6% and 89.9% for PCR-LF. Although the difference in sensitivity between bacterial cultures and PCR-LF was not significant, when our analysis was limited to cases with suspected periprosthetic joint infection, the sensitivity of PCR-LF (66.1%) was superior to that of bacterial cultures (42.9%). Conclusion: This study indicates that PCR-LF is a useful method for diagnosing orthopedic-related infections.
Inflammation | 2012
Shin Nihonyanagi; Yuhsaku Kanoh; Kiyomi Okada; Toshiki Uozumi; Yukumasa Kazuyama; Tokiko Yamaguchi; Nobuhiko Nakazaki; Keizou Sakurai; Yasuyoshi Hirata; Shinichi Munekata; Shinichi Ohtani; Tsuyoshi Takemoto; Yuki Bandoh; Tohru Akahoshi
The Journal of the Japanese Association for Infectious Diseases | 2013
Tomoyo Onuki; Shin Nihonyanagi; Masaki Nakamura; Toshimitsu Ide; Jun Hattori; Yuhsaku Kanoh; Kazui Soma
The Journal of the Japanese Association for Infectious Diseases | 2006
Shin Nihonyanagi; Yasuyosi Hirata; Tooru Akabosi; Yukinobu Uchiyama; Noboru Yamaura; Keisuke Sunakawa; Matsuhisa Inoue
The Journal of the Japanese Association for Infectious Diseases | 2012
Shin Nihonyanagi; Yuzuru Adachi; Tomoyo Onuki; Nobuhiko Nakazaki; Yasuyosi Hirata; Kuniko Fujiki; Yoko Takayama; Yuhsaku Kanoh; Yuki Bandoh; Yurika Dantsuji; Hideaki Hanaki; Keisuke Sunakawa
The Journal of the Japanese Association for Infectious Diseases | 2008
Tomoko Hisamatsu; Nobuhiko Nakazaki; Shin Nihonyanagi; Yasuyoshi Hirata; Yoko Takayama; Shinichi Ohtani; Tohru Akahoshi; Keisuke Sunakawa
日本化学療法学会雜誌 = Japanese journal of chemotherapy | 2013
Masaki Nakamura; Yoko Takayama; Rumiko Kondo; Nobuhiko Nakazaki; Shin Nihonyanagi; Chie Sato; Yuko Tsunoda; Kuniko Fujiki; Ynmiko Takagi; Yasuyoshi Hirata; Hideaki Hanaki; Keisuke Sunakawa